Dow Down 0.32% Nasdaq Down 0.62%

GenVec, Inc. (GNVC)

-NasdaqCM
0.78 Down 0.01(1.28%) Apr 29, 4:00PM EDT
|After Hours : 0.83 Up 0.05 (6.41%) Apr 29, 5:57PM EDT
Prev Close:0.79
Open:0.76
Bid:N/A
Ask:0.98 x 4000
1y Target Est:5.00
Beta:3.56072
Earnings Date:May 6 - May 10 (Est.)
Day's Range:0.75 - 0.80
52wk Range:0.35 - 3.69
Volume:105,193
Avg Vol (3m):124,656
Market Cap:13.47M
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GNVC

Comparison

Symbol% ChgMkt Cap
GNVCDown 1.28%13.47M
MRKDown 1.61%151.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.30
Quarterly EPS Est (Mar-16) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback